Metoprolol Succinate
Product Images NDC 0527-2602

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 0527-2602). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 mg Label (100mg)

Metoprolol Succinate 100 mg extended-release tablets label from Lannett Company, Inc., showing package content of 100 tablets. The label states the product is prescription only and manufactured by AstraZeneca AB in Sweden, with Lannett as the labeler in Philadelphia, PA. The label includes storage instructions and NDC 0527-2602-37.*

FDA Label Image

200 mg Label (200mg)

Metoprolol Succinate 200 mg extended-release tablets packaging label showing 100 tablets. Manufactured by AstraZeneca AB in Sweden for Lannett Company, Inc. The label includes dosage instructions, storage warnings, and the Lannett logo. NDC number 0527-2603-37 is visible with barcode.*

FDA Label Image

25 mg Label (25mg)

Label for METOPROLOL SUCCINATE 25 mg extended-release tablets, with 100 tablets per container. The label indicates Rx only and shows the manufacturer as Lannett Company, Inc., Philadelphia, PA. It also references AstraZeneca AB, Sweden as another manufacturing site. The label includes directions for storage, dosage instructions, and a barcode.*

FDA Label Image

50 mg Label (50mg)

Label for Metoprolol Succinate extended-release tablets, 50 mg strength, in a package of 100 tablets. The label shows the product name, strength, dosage form, and manufacturer information including Lannett Company, Inc. It also includes regulatory details and storage instructions, with the batch labeled as a product of Sweden and manufacturing by AstraZeneca AB.*

FDA Label Image

Structuralformula (Image 01)

Chemical structure depicting the active ingredient metoprolol succinate. The structure shows two metoprolol molecules complexed with succinate, highlighting functional groups including hydroxyl, ether, amine, and carboxyl groups.*

FDA Label Image

Merit Graphic (Image 02)

A forest plot chart titled "Results for Subgroups in MERIT-HF" showing relative risk and 95% confidence intervals for three outcomes: Total Mortality, Total Mortality or All-Cause Hospitalization, and Total Mortality or Hospitalization for Heart Failure, comparing metoprolol succinate extended release tablets versus placebo across various subgroups such as geographic region, NYHA class, ejection fraction, etiology, sex, race, previous myocardial infarction, diabetes, hypertension, and heart rate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.